| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Dev. Op. Officer | Chief Dev. Op Officer | Chief Dev.op Off +3 more
2 companies
Lewis Tanya is a Chief Dev. Op. Officer at Replimune Group, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $854K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | REPL Replimune Group, Inc. | Chief Dev. Op. Officer | Sell | 12,860 | $24.06 | $309,394.95 | -4.5% | -17.9% | -63.4% | |
| May 16, 2023 | REPL Replimune Group, Inc. | Chief Dev. Op. Officer | Sell | 12,207 | $18.05 | $220,336.35 | -7.6% | +6.5% | -63.2% | |
| May 16, 2022 | REPL Replimune Group, Inc. | Chief Dev. Op Officer | Sell | 5,473 | $14.59 | $79,851.07 | -4.3% | +42.1% | +27.3% | |
| Feb 11, 2021 | KPTI Karyopharm Therapeutics Inc. | EVP, Chief Reg. Affairs | Sell | 2,046 | $15.52 | $31,752.08 | -33.1% | - | - | |
| Oct 30, 2020 | KPTI Karyopharm Therapeutics Inc. | EVP,Chief Reg.&Quality Officer | Sale+OE | 226 | $15.58 | $3,521.08 | -29.5% | - | - |